Malignant Myoepithelioma Arising from the Upper Arm With Brachial Plexus Involvement: A Rare Case
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
942-946
DOI: 10.21873/cdp.10596
Immune Checkpoint Inhibitor Resistance in Rectal Adenocarcinoma Containing a Mismatch Repair Deficiency Component: A Case Report
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
934-941
DOI: 10.21873/cdp.10595
Jejunal Mixed Adenoneuroendocrine Carcinoma (MANEC) With a Novel PTPRK-RSPO3 Fusion Initially Presenting as a Large Ovarian Mass: Diagnostic Challenges and Poor Prognosis
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
928-933
DOI: 10.21873/cdp.10594
Two Cases of Uterine Small-cell Neuroendocrine Carcinoma With Somatostatin-receptor-type-2 (SSTR2) Expression and Minor Components of Endocervical Adenocarcinoma
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
918-927
DOI: 10.21873/cdp.10593
Prognostic Significance of Number of Liver Metastases in Patients With Advanced Pancreatic Cancer Receiving Nab-paclitaxel Plus Gemcitabine
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
909-917
DOI: 10.21873/cdp.10592
Preoperative Magnetic Resonance Imaging Findings of the Transition Zone Predict Incidental Prostate Cancer in HoLEP
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
900-908
DOI: 10.21873/cdp.10591
First-line Enfortumab Vedotin Plus Pembrolizumab in Platinum-ineligible Advanced Urothelial Carcinoma
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
890-899
DOI: 10.21873/cdp.10590
Real-world Outcomes of First-line Platinum-based Chemotherapy in Patients Aged 80 Years or Older With Metastatic Urothelial Carcinoma
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
882-889
DOI: 10.21873/cdp.10589
Prognostic Impact of Recurrence Location in Locally Recurrent Rectal Cancer: A Single-Center Retrospective Study
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
872-881
DOI: 10.21873/cdp.10588
Reduced HMGCR Expression in Clear Cell Renal Cell Carcinoma Is Associated With Poor Patient Prognosis
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
864-871
DOI: 10.21873/cdp.10587
Co-expression of the Mammaglobin (SCGB2A2) Gene With hsa-miR-184 and hsa-miR-190b Indicates Its Possible Role in Oncogenic Pathways in Breast Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
843-863
DOI: 10.21873/cdp.10586
Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
825-832
DOI: 10.21873/cdp.10584
Transcriptomic Association Between Poliovirus Receptor (PVR/CD155) and Claudin Signaling Pathways in Colorectal Cancer
Cancer Diagnosis & Prognosis
Sep-Oct;
6(5):
833-842
DOI: 10.21873/cdp.10585
Diagnostic and Prognostic Applications of PET/CT in Small-cell Lung Cancer
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
608-618
DOI: 10.21873/cdp.10561
Impact of Local Treatment of the Primary Tumor on Overall Survival in De Novo Metastatic Breast Cancer: A Systematic Review and Meta-analysis
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
619-629
DOI: 10.21873/cdp.10562
Lipid Profiles in Breast Cancer: Clinical Associations and Biological Insights
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
630-638
DOI: 10.21873/cdp.10563
CDKN2A mRNA Over-expression Is Associated With CD8+ T Cell Exclusion and IDO1-Mediated Adaptive Immune Resistance in Gastric Adenocarcinoma
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
639-648
DOI: 10.21873/cdp.10564
HER2 Expression and Nuclear Localization in Clear Cell Renal Cell Carcinoma: Implications for Prognosis and Therapeutic Targeting
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
649-659
DOI: 10.21873/cdp.10565
Optimized Prostate Cancer Stage Classification Using XGBoost Based on Racial miRNA Expression
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
660-673
DOI: 10.21873/cdp.10566
Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
Cancer Diagnosis & Prognosis
Jul-Aug;
6(4):
674-681
DOI: 10.21873/cdp.10567